HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Duration of protective immunity conferred by maternal tetanus toxoid immunization: further evidence from Matlab, Bangladesh.

AbstractOBJECTIVES:
Although maternal tetanus immunization has been shown to be highly effective in the prevention of neonatal tetanus, unresolved questions remain concerning the required minimum number of doses and the resulting duration of effective immunity. This study examined the duration of effective immunity against neonatal tetanus provided by maternal tetanus immunization.
METHODS:
A randomized, double-blind cholera vaccine trial of 41,571 children and nonpregnant adult women carried out in 1974 in the Matlab comparison area of rural Bangladesh provided a unique opportunity to address dose and immunity issues.
RESULTS:
Children of women who received either 1 or 2 injections of tetanus toxoid experienced 4- to 14-day mortality levels consistently lower than those of children of unimmunized mothers. Analysis of neonatal-tetanus-related mortality showed that 2 injections of tetanus toxoid provided significant protection for subsequent durations of up to 12 or 13 years.
CONCLUSIONS:
The data demonstrate that a limited-dose regimen of maternal tetanus toxoid provides significant and extended protection against the risk of neonatal tetanus death.
AuthorsM A Koenig, N C Roy, T McElrath, M Shahidullah, B Wojtyniak
JournalAmerican journal of public health (Am J Public Health) Vol. 88 Issue 6 Pg. 903-7 (Jun 1998) ISSN: 0090-0036 [Print] United States
PMID9618617 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tetanus Toxoid
Topics
  • Adolescent
  • Adult
  • Bangladesh (epidemiology)
  • Cause of Death
  • Child
  • Child, Preschool
  • Developing Countries
  • Female
  • Follow-Up Studies
  • Humans
  • Immunity, Maternally-Acquired (drug effects, immunology)
  • Immunization Programs
  • Immunization Schedule
  • Infant
  • Infant, Newborn
  • Male
  • Pregnancy
  • Survival Rate
  • Tetanus (immunology, mortality, prevention & control, transmission)
  • Tetanus Toxoid (administration & dosage, adverse effects, immunology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: